We are live on
!
Find out more
CCM
Carderock Capital Management Portfolio holdings
AUM
$456M
1-Year Est. Return
31.89%
This Fund
S&P 500
This Quarter
Est. Return
+5.73%
1 Year Est. Return
+31.89%
3 Year Est. Return
+88.65%
5 Year Est. Return
+111.4%
10 Year Est. Return
+513.53%
AUM
$227M
AUM Growth
+$5.24M
(+2.4%)
Cap. Flow
-$5.55M
Cap. Flow
% of AUM
-2.45%
Top 10 Holdings %
Top 10 Hldgs %
28.45%
Holding
77
New
5
Increased
16
Reduced
50
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$2.48M |
| 2 |
Phillips 66
PSX
|
+$1.88M |
| 3 |
Becton Dickinson
BDX
|
+$1.82M |
| 4 |
SLB Ltd
SLB
|
+$730K |
| 5 |
Chevron
CVX
|
+$489K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$5.73M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$886K |
| 3 |
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
|
+$868K |
| 4 |
Church & Dwight Co
CHD
|
+$768K |
| 5 |
Keurig Dr Pepper
KDP
|
+$674K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.34% |
| 2 | Healthcare | 18.56% |
| 3 | Industrials | 11.08% |
| 4 | Financials | 9.34% |
| 5 | Consumer Discretionary | 7.91% |
Similar funds
HFF
FIM
EGP
AWM
EIA
BRF
TCMP
FC
Carderock Capital Management's Q4 2017 Portfolio in Review
As of Q4 2017, Carderock Capital Management held 77 positions worth $227M, up 2.4% from $222M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Carderock Capital Management's Q4 2017 filing shows 5 new, 16 increased, 50 reduced and 2 closed positions. Its largest new stake was Marathon Petroleum: 40,565 shares worth $2.68M. The largest sale was CR Bard Inc., an estimated $5.73M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.
- Carderock Capital Management's largest Q4 2017 buy was Marathon Petroleum: 40,565 shares worth $2.68M.
- Carderock Capital Management added most to Becton Dickinson in Q4 2017, an estimated $1.82M increase.
- Carderock Capital Management's biggest Q4 2017 reduction was Thermo Fisher Scientific, cutting an estimated $886K.
- Carderock Capital Management fully exited CR Bard Inc. in Q4 2017, selling an estimated $5.73M.
- Carderock Capital Management's ten largest holdings make up 28% of its $227M portfolio in Q4 2017.
- Carderock Capital Management opened 5 new positions and closed 2 in Q4 2017.
- Carderock Capital Management's portfolio value rose 2.4% quarter-over-quarter to $227M.
Based on Carderock Capital Management's 13F filing for Q4 2017, filed 25 Jan 2018.